RGNX CIK: 1590877

REGENXBIO Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
219
FY22:
−207
FY23:
−218
FY24:
−173
FY25:
−124
Change from FY21 to FY25
millions USD
FY21:
−407
FY22:
−11.9
FY23:
191
FY24:
103
FY25:
−15.9
Change from FY21 to FY25
millions USD
FY21:
195
FY22:
−28.8
FY23:
−35.0
FY24:
92.7
FY25:
117
millions USD
FY21:
7.48
FY22:
−248
FY23:
−62.4
FY24:
23.0
FY25:
−23.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
135
FY22:
−238
FY23:
−228
FY24:
−176
FY25:
−126

All amounts in millions USD Data source:SEC EDGAR